IQ EQ Fund Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
IQ EQ Fund Management's PACB Position: Q3 2026 in Review
IQ EQ Fund Management increased its Pacific Biosciences (PACB) stake by 4.2% in Q3 2026, buying an estimated $100K and bringing the position to 1,765,444 shares worth $4.18M. The position accounts for 0.26% of the portfolio, ranked #102.
IQ EQ Fund Management first reported a position in PACB in Q2 2024 and has held it in 10 quarters since. 146 funds tracked by Wall St. Rank hold PACB as of Q3 2026.
- IQ EQ Fund Management held 1,765,444 shares of Pacific Biosciences worth $4.18M as of Q3 2026.
- IQ EQ Fund Management bought 70,898 Pacific Biosciences shares in Q3 2026, an estimated $100K.
- Pacific Biosciences made up 0.26% of IQ EQ Fund Management's portfolio in Q3 2026, its #102 holding.
- IQ EQ Fund Management first reported a position in Pacific Biosciences in Q2 2024 and has held it in 10 quarters since.
- 146 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.
Based on IQ EQ Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.